Converging on a Cure: The Roads to Predictive Immunotherapy

Convergence science teams integrating clinical, biological, engineering, and computational expertise are inventing new forecast systems to monitor and predict evolutionary changes in tumor and immune interac-tions during early cancer progression and therapeutic response. The resulting methods should inform a new predictive medicine paradigm to select adaptive immunotherapeutic regimens personalized to patients' tumors at a given time during their cancer progression for durable patient response.

Automated summary

Convergence science teams are developing new forecast systems to monitor and predict changes in tumor and immune interactions during early cancer progression and treatment response, by integrating clinical, biological, engineering, and computational expertise. These methods are expected to support the selection of adaptive immunotherapeutic regimens personalized to each patient's tumor at a specific time during the cancer journey, for long-lasting patient response.